Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy.
Miranda-Bautista J, de Gracia-Fernández C, López-Ibáñez M, Barrientos M, Gallo-Moltó A, González-Arias M, González-Gil C, Díaz-Redondo A, Marín-Jiménez I, Menchén L. Miranda-Bautista J, et al. Among authors: menchen l. Dig Dis Sci. 2015 Jul;60(7):2130-5. doi: 10.1007/s10620-015-3577-0. Epub 2015 Feb 14. Dig Dis Sci. 2015. PMID: 25680875
[Osteoporosis and inflammatory bowel disease].
Menchén L, Ripoll C, Bretón I, Moreno C, de la Cuerda C, Camblor M, García-Peris P, González-Lara V, Cos E. Menchén L, et al. Nutr Hosp. 2005 Jan-Feb;20(1):26-37. Nutr Hosp. 2005. PMID: 15762417 Spanish.
Refeeding syndrome in a patient with Crohn's disease.
Hernando A, Bretón I, Marín-Jimenez I, Menchén L. Hernando A, et al. Among authors: menchen l. J Clin Gastroenterol. 2008 Apr;42(4):430-1. doi: 10.1097/01.mcg.0000247989.04463.54. J Clin Gastroenterol. 2008. PMID: 18277892 No abstract available.
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response.
González-Lama Y, López-San Román A, Marín-Jiménez I, Casis B, Vera I, Bermejo F, Pérez-Calle JL, Taxonera C, Martínez-Silva F, Menchén L, Martínez-Montiel P, Calvo M, Carneros JA, López P, Mendoza JL, Milicua JM, Huerta A, Sánchez F, Abreu L, López-Palacios N, Maté J, Gisbert JP; Group for the Study of Inflammatory Bowel Diseases from Madrid (ENICMAD). González-Lama Y, et al. Among authors: menchen l. Gastroenterol Hepatol. 2008 Aug-Sep;31(7):421-6. doi: 10.1157/13125587. Gastroenterol Hepatol. 2008. PMID: 18783686
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
Fortea-Ormaechea JI, González-Lama Y, Casis B, Chaparro M, López Serrano P, Van Domselaar M, Bermejo F, Pajares R, Ponferrada A, Vera MI, Martínez Montiel P, Gisbert JP, Pérez-Calle JL, López San Román A, Abreu L, Menchén LA, Marín-Jiménez I. Fortea-Ormaechea JI, et al. Among authors: menchen la. Gastroenterol Hepatol. 2011 Aug-Sep;34(7):443-8. doi: 10.1016/j.gastrohep.2011.04.001. Epub 2011 Jul 2. Gastroenterol Hepatol. 2011. PMID: 21724297
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.
Barreiro-de Acosta M, García-Bosch O, Souto R, Mañosa M, Miranda J, García-Sanchez V, Gordillo J, Chacon S, Loras C, Carpio D, Maroto N, Menchén L, Rojas-Feria M, Sierra M, Villoria A, Marin-Jimenez I; Grupo joven GETECCU. Barreiro-de Acosta M, et al. Among authors: menchen l. Inflamm Bowel Dis. 2012 May;18(5):812-7. doi: 10.1002/ibd.21821. Epub 2011 Aug 8. Inflamm Bowel Dis. 2012. PMID: 21826765
83 results